Search research articles
Contact Us
Filters
Showing results (741-750 of 839) with videos related to
Page
of 84
Sort By:
Cancer
|
September 13, 2021
Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer
Peter S Kirk, Kehao Zhu, Yingye Zheng, et al.
JAMA Oncology
|
September 23, 2021
Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer
Rahul Aggarwal, Nicholas R Rydzewski, Li Zhang, et al.
The Journal of Urology
|
July 13, 2022
Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance
Christopher P Filson, Kehao Zhu, Yijian Huang, et al.
EMBO Reports
|
November 1, 2019
Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasis
Amal M El-Naggar, Syam Prakash Somasekharan, Yemin Wang, et al.
The Journal of Urology
|
April 30, 2025
Magnetic Resonance Imaging at Second Surveillance Biopsy After Diagnosis in Patients With Grade Group 1 Prostate Cancer in the Canary Prostate Active Surveillance Study
Meera R Chappidi, Lisa F Newcomb, Yingye Zheng, et al.
The Journal of Pathology
|
February 20, 2015
Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development
Qian Wang, Rae-Anne Hardie, Andrew J Hoy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2020
Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer
James A Eastham, Glenn Heller, Susan Halabi, et al.
Cancer Research
|
May 14, 2021
SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate Cancer
Rafael S Martinez, Mark J Salji, Linda Rushworth, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 4, 2025
Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer
Betul Ersoy-Fazlioglu, Shreyas Lingadahalli, Umut Berkay Altintas, et al.
European Urology Oncology
|
September 25, 2025
Prognostic Significance of the Cytoplasmic Expression of UDP-glucuronosyltransferase 2B17 in Localized Prostate Cancer: Insights from the Canadian Prostate Cancer Biomarker Network and PROCURE Multi-institutional Cohorts
Ashwini Uchil, Louis Lacombe, Hélène Hovington, et al.
Page
of 84
Search research articles
Search
Showing results (741-750 of 839) with videos related to
Sort By:
Page
of 84
Cancer
|
September 13, 2021
Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer
Peter S Kirk, Kehao Zhu, Yingye Zheng, et al.
JAMA Oncology
|
September 23, 2021
Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer
Rahul Aggarwal, Nicholas R Rydzewski, Li Zhang, et al.
The Journal of Urology
|
July 13, 2022
Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance
Christopher P Filson, Kehao Zhu, Yijian Huang, et al.
EMBO Reports
|
November 1, 2019
Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasis
Amal M El-Naggar, Syam Prakash Somasekharan, Yemin Wang, et al.
The Journal of Urology
|
April 30, 2025
Magnetic Resonance Imaging at Second Surveillance Biopsy After Diagnosis in Patients With Grade Group 1 Prostate Cancer in the Canary Prostate Active Surveillance Study
Meera R Chappidi, Lisa F Newcomb, Yingye Zheng, et al.
The Journal of Pathology
|
February 20, 2015
Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development
Qian Wang, Rae-Anne Hardie, Andrew J Hoy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2020
Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer
James A Eastham, Glenn Heller, Susan Halabi, et al.
Cancer Research
|
May 14, 2021
SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate Cancer
Rafael S Martinez, Mark J Salji, Linda Rushworth, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 4, 2025
Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer
Betul Ersoy-Fazlioglu, Shreyas Lingadahalli, Umut Berkay Altintas, et al.
European Urology Oncology
|
September 25, 2025
Prognostic Significance of the Cytoplasmic Expression of UDP-glucuronosyltransferase 2B17 in Localized Prostate Cancer: Insights from the Canadian Prostate Cancer Biomarker Network and PROCURE Multi-institutional Cohorts
Ashwini Uchil, Louis Lacombe, Hélène Hovington, et al.
Page
of 84